Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study - Wikidata - awgldk - TriplyDB

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

http://www.wikidata.org/entity/Q33409117

about

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models Pretreatment but not subsequent coincubation with midazolam reduces the cytotoxicity of temozolomide in neuroblastoma cells A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncolo Desmoplastic Small Round Blue Cell Tumor: A Review of Treatment and Potential Therapeutic Genomic Alterations.Effect of O6-methylguanine-DNA methyltransferase methylation in medulloblastoma.Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.

P2860

Q27345024-3AE79B19-BE24-4402-A777-6D464389BAAE Q35811082-D24B1BD7-12AD-47EC-B69E-8A87B49F8586 Q39078623-01F3B8A9-A8A4-48C2-8487-7488F533695E Q46635839-0D7E4C5A-4D75-4A5A-90DC-8D9108431EC7 Q47128186-2607C3A4-BDE8-4677-A6D5-02B58348D491 Q47133403-160B64D4-A458-43A8-AD77-FF3F04C66B19 Q47296254-57428EA4-ACC1-41DB-822F-9F43E9312387

P2860

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

http://www.wikidata.org/entity/Q33409117

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@ast

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@en

type

label

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@ast

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@en

prefLabel

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@ast

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@en

P1433

Q33409117-710F17A4-B5E5-48CA-92BE-888F731A3ADE

P1476

Q33409117-5D68CEAF-B5C9-4BF0-98A8-8E80906A8C22

P2093

Q33409117-030F7465-F261-4A82-9DA0-0398914EAFCF

Q33409117-04985771-CB2B-4449-9D59-3B09A57A7614

Q33409117-21075511-EC56-40F2-8F91-4CE41A7BE685

Q33409117-221B7FB7-D8BD-46FC-B171-40DA71BD8B42

Q33409117-40407005-0311-49F0-8FFD-5A5C7F832959

Q33409117-4920568E-2892-4BBB-BC06-62B541420F5A

Q33409117-5490AAF3-DEF4-4220-8CD7-B94F28E9BCD7

Q33409117-663939D2-B512-44D7-9A6D-6B55A4D21FFA

Q33409117-7232F05C-6031-455E-BE04-0910B864EC0C

Q33409117-75A4E80D-10EF-47C1-81A4-29C561ABE045

P2860

Q33409117-011B2343-DFBD-4C2D-9A6D-F27662731E12

Q33409117-06D976DB-FF76-4053-B58D-CFD4E4DDE59E

Q33409117-0C777536-2F0A-4826-81AF-B5E9C218F995

Q33409117-0DB95E56-8E52-4C4B-8060-B48E2A4890B9

Q33409117-136037CA-1AD3-4D3D-BEB4-A596AC2A823C

Q33409117-14D3CFD5-5F8E-4401-953F-C720E7EA42E3

Q33409117-26AD14F6-5DCE-4BC8-83BD-923BE9140E28

Q33409117-326FE2D5-7712-420F-93C4-6D3FDD9F64E8

Q33409117-3645A336-B850-4EF1-8384-F71BD1C56444

Q33409117-3E8E220F-8C26-481F-BCB8-E94CEAB92081

P304

Q33409117-10D0CBAF-0A89-49D5-88BE-899954B74FD4

P31

Q33409117-8D78280D-938B-4F25-BD98-B1B2FF7DDF53

P356

Q33409117-D37DE282-E342-4F83-9FDE-4E4810BEDFC4

P433

Q33409117-847A6DB9-07D9-4B2F-A8AC-53DCEC4E372F

P478

Q33409117-96CCE156-C29F-4626-A6F3-084C4349CFA2

P50

Q33409117-0C307E02-F120-4D5D-90F7-0725D964797F

Q33409117-1FEEA963-E125-44C5-9F03-A19C71F4312D

Q33409117-9ACD147A-E215-42D6-9CEF-C0C307405098

Q33409117-CAF1418A-CFB8-442C-8D37-0B5740AE34EE

P577

Q33409117-DD449DDB-1DF0-429B-A8FA-FD3C87C4C473

P5875

Q33409117-ACDEA21F-5BCA-48FC-AB34-B09D3699A300

P698

Q33409117-A0AA5F15-5D00-4128-BADE-9F31ECCCD70C

P921

Q33409117-D7374DF9-4C32-4095-B178-5EAEB67ECB1A

P932

Q33409117-D2CA67DA-135D-4F36-8B92-85047638ABC2

P356

P1433

P1476

Phase II study of irinotecan i ...... CC and SIOPE brain tumor study

@en

P2093

Andrew Dorman

http://www.w3.org/2001/XMLSchema#string

Aurora Breazna

http://www.w3.org/2001/XMLSchema#string

Birgit Geoerger

http://www.w3.org/2001/XMLSchema#string

Danuta Perek

http://www.w3.org/2001/XMLSchema#string

Edward Estlin

http://www.w3.org/2001/XMLSchema#string

European Consortium Innovative ...... logy (SIOPE) brain tumor group

http://www.w3.org/2001/XMLSchema#string

Gary Nicolin

http://www.w3.org/2001/XMLSchema#string

Isabelle Aerts

http://www.w3.org/2001/XMLSchema#string

Joris Verlooy

http://www.w3.org/2001/XMLSchema#string

Josep Sanchez de Toledo Codina

http://www.w3.org/2001/XMLSchema#string

P2860

Reporting results of cancer treatment

Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

Temozolomide in resistant or relapsed pediatric solid tumors.

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.

P304

1236-1243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOT097

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Darren Hargrave

P577

2013-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262043907

http://www.w3.org/2001/XMLSchema#string

P698

23857707

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

3748925

http://www.w3.org/2001/XMLSchema#string